ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

121
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
Refresh
bullishAstellas Pharma
02 Feb 2022 17:45

Astellas Pharma (4503) Buyback - Short-Term Pressure Catalyst

Astellas Pharma announced decent earnings and a buyback. It looks small but Astellas is not that liquid. This has impact. A short-term trade...

Logo
263 Views
Share
11 Jan 2022 02:43

Takeda: Excessive Reaction to Recent Setback in Trials; Drop in Share Price Offer Attractive Entry

Most recent setbacks in Takeda’s drug development trials have caused a panic in the market whether the company will be able to replace its top...

Share
02 Oct 2021 22:48

Kintor Pharmaceutical (9939 HK) – Dual Play on COVID and Solid Tumors

Kintor Pharma is set to fly high ahead of its first product launch in China for prostate cancer, which has high unmet medical need. COVID-19...

Logo
345 Views
Share
16 Aug 2020 07:37

Asia Short Interest Weekly: AliHealth, Meituan, SunnyOptical, WuXi Apptec, Canon, Lasertec, Seegene

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
292 Views
Share
25 Jul 2020 10:01

Asia Short Interest Weekly: JD, Netease, CSPC, Alibaba, Meituan, Tencent, Fanuc, Mitsubishi, Toshiba

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
324 Views
Share
x